ENCOURAGING OUTCOMES OF SECOND ALLOGENEIC STEM CELL TRANSPLANT FOR ACUTE LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES FROM TWO CENTERS IN SÃO PAULO, BRAZIL
Objectives: Second allogeneic Hematopoietic Stem Cell Transplant (HSCT) is the only curative treatment option for patients who relapse after a first transplant for malignant diseases. Previously reported outcomes for this intervention are often dismal, with high Relapse Incidence (RI), Non-Relapse M...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2024-10-01
|
| Serie: | Hematology, Transfusion and Cell Therapy |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2531137924021023 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
